Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones

NCT01077284 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricosuria
Kidney Stones

Interventions

DRUG: Febuxostat
DRUG: Allopurinol
DRUG: Placebo

Sponsor

Takeda